Novacyt (NCYT) EUR0.0667 (CDI)

- Add to watchlist
- Create an alert
- This stock can be held in a




39.80p
40.70p
73.60p
£28.11 million
39.80p
39.44p
36.10p
n/a
0.20p (0.50%) Previous:
0.20p
5,016
n/a
7,500
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2024 | 31/12/2023 |
---|---|---|
Revenue (£m) | 19.63 | 10.62 |
Profit before tax (£m) | (39.43) | (24.46) |
Adjusted EPS (p): | (55.00) | (34.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Novacyt subsidiary fined for HSE breach at 'historical operation'
12 September 2025 10:27
-
Novacyt flags strong full-year revenue growth
30 January 2025 12:11
-
Novacyt recovers £12.2m in VAT after settling DHSC dispute
22 August 2024 12:29
-
Notice of Results
18 September 2025 07:00
-
Appointment of Joint Corporate Broker
15 September 2025 07:00
-
Resolution re. Lab 21 HSE Prosecution
12 September 2025 10:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.